Indoco Remedies Ltd Q4 consolidated net profit slides to Rs. 5.36 crore

INDOCO REMEDIES LTD. has reported financial results for the period ended March 31, 2020.

Financial Results (Q4 FY19-20) - QoQ Comparison

The company has reported net sales of Rs.272.49 crores during the period ended March 31, 2020 as compared to Rs.290.07 crores during the period ended December 31, 2019.

The company has posted net profit of Rs.5.36 crores for the period ended March 31, 2020 as against Rs.9.10 crores for the period ended December 31, 2019.

The company has reported EPS of Rs.0.58 for the period ended March 31, 2020 as compared to Rs.0.99 for the period ended December 31, 2019.

Financials	Q4 FY19-20	Q3 FY19-20	% Change
Total Income	₹ 272.49 crs	₹ 290.07 crs	-6.06%
Net Profit	₹ 5.36 crs	₹ 9.10 crs	-41.1%
EPS	₹ 0.58	₹ 0.99	-41.41%

Financial Results (Q4 FY19-20) - YoY Comparison

The company has reported net sales of Rs.272.49 crores during the period ended March 31, 2020 as compared to Rs.257 crores during the period ended March 31, 2019.

The company has posted net profit of Rs.5.36 crores for the period ended March 31, 2020 as against Rs.11.49 crores for the period ended March 31, 2019.

The company has reported EPS of Rs.0.58 for the period ended March 31, 2020 as compared to Rs.1.25 for the period ended March 31, 2019.

Financials	Q4 FY19-20	Q4 FY18-19	% Change
Total Income	₹ 272.49 crs	₹ 257 crs	6.03%
Net Profit	₹ 5.36 crs	₹ 11.49 crs	-53.35%
EPS	₹ 0.58	₹ 1.25	-53.6%

Financial Results (Year ended FY 2019-20) - YoY Comparison

The company has reported net sales of Rs.1109.03 crores during the 12 months period ended March 31, 2020 as compared to Rs.974.59 crores during the 12 months period ended March 31, 2019.

The company has posted net profit of Rs.24.12 crores for the 12 months period ended March 31, 2020 as against net loss of Rs.(2.90) crores for the 12 months period ended March 31, 2019.

The company has reported EPS of Rs.2.62 for the 12 months period ended March 31, 2020 as compared to Rs.(0.32) for the 12 months period ended March 31, 2019.

Financials	FY2019-20	FY2018-19	% Change
Total Income	₹ 1109.03 crs	₹ 974.59 crs	13.79%
Net Profit	₹ 24.12 crs	₹ (2.90) crs	931.72%
EPS	₹ 2.62	₹(0.32)	918.75%

Commenting on the 4th quarter results, Aditi Panandikar, Managing Director, Indoco Remedies Ltd., said, "The Company's Domestic and International Sales for the quarter got impacted due to supply chain issues and the ban on Paracetamol exports in the month of March'20 due to Covid-19. However, we have adapted to the new normal and are trying to minimize the impact of the pandemic."

Shares of INDOCO REMEDIES LTD. was last trading in BSE at Rs.222.25 as compared to the previous close of Rs. 215.8. The total number of shares traded during the day was 15852 in over 977 trades.

The stock hit an intraday high of Rs. 225 and intraday low of 220. The net turnover during the day was Rs. 3518527.

Source : Equity Bulls

Keywords